Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ACONW

Aclarion (ACONW)

Aclarion Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACONW
일자시간출처헤드라인심볼기업
2025/01/1807:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2025/01/1622:50Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONWAclarion Inc
2025/01/1514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
2025/01/1509:11Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:ACONWAclarion Inc
2025/01/1107:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONWAclarion Inc
2025/01/0621:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2025/01/0621:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACONWAclarion Inc
2025/01/0404:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2025/01/0404:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2024/12/2707:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONWAclarion Inc
2024/12/0220:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONWAclarion Inc
2024/11/2806:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2024/11/2306:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONWAclarion Inc
2024/11/2122:00GlobeNewswire Inc.Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNASDAQ:ACONWAclarion Inc
2024/11/1503:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONWAclarion Inc
2024/11/1405:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACONWAclarion Inc
2024/11/0906:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
2024/11/0520:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
2024/11/0520:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
2024/11/0514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
2024/11/0420:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACONWAclarion Inc
2024/10/2606:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONWAclarion Inc
2024/10/2513:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
2024/10/1605:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACONWAclarion Inc
2024/10/1205:36Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACONWAclarion Inc
2024/10/1205:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2024/10/1020:00GlobeNewswire Inc.Aclarion to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ACONWAclarion Inc
2024/10/0205:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
2024/09/2719:57GlobeNewswire Inc.Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesNASDAQ:ACONWAclarion Inc
2024/09/2505:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
 검색 관련기사 보기:NASDAQ:ACONW